PTKFY may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 6 cases where PTKFY's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where PTKFY's RSI Indicator exited the oversold zone, of 8 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
The Momentum Indicator moved above the 0 level on November 22, 2024. You may want to consider a long position or call options on PTKFY as a result. In of 21 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for PTKFY just turned positive on November 22, 2024. Looking at past instances where PTKFY's MACD turned positive, the stock continued to rise in of 21 cases over the following month. The odds of a continued upward trend are .
PTKFY moved above its 50-day moving average on December 06, 2024 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for PTKFY crossed bullishly above the 50-day moving average on December 12, 2024. This indicates that the trend has shifted higher and could be considered a buy signal. In of 9 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 125 cases where PTKFY Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating for company is (best 1 - 100 worst), which means the company is slightly undervalued. The valuation of the company is based on a proprietary formula which takes into account a set of fundamentals and gives us an estimate of the price per share for the company. We then compare this estimate with the current price per share. As a result, this company is rated as undervalued in the industry. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.794) is normal, around the industry mean (5.632). P/E Ratio (30.030) is within average values for comparable stocks, (48.974). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.004). Dividend Yield (0.018) settles around the average of (0.164) among similar stocks. P/S Ratio (3.427) is also within normal values, averaging (3.643).
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. PTKFY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PTKFY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 76, placing this stock worse than average.
Industry PharmaceuticalsMajor
A.I.dvisor tells us that PTKFY and SNPHF have been poorly correlated (+6% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PTKFY and SNPHF's prices will move in lockstep.
Ticker / NAME | Correlation To PTKFY | 1D Price Change % | ||
---|---|---|---|---|
PTKFY | 100% | N/A | ||
SNPHF - PTKFY | 6% Poorly correlated | N/A | ||
RHHVF - PTKFY | 4% Poorly correlated | +0.08% | ||
RHHBY - PTKFY | 2% Poorly correlated | +1.13% | ||
RHHBF - PTKFY | 1% Poorly correlated | +6.60% | ||
OTSKF - PTKFY | 0% Poorly correlated | N/A | ||
More |